Medipharm Labs Sees PI Financial, Mackie Research Drop Estimates, Price Targets
Medipharm Labs (TSX: LABS) reported Q1 2020 results on Thursday, June 18, which showed it’s revenue drop by 66% on
Read more
Medipharm Labs
Hexo Has Filed A $35 Million Counterclaim Against Medipharm Labs
It appears that Hexo Corp (TSX: HEXO) (NYSE: HEXO) has filed a counterclaim against Medipharm Labs (TSX: LABS) in relation
Read more
Medipharm Labs Sees Revenues Crater 65.8% Quarter Over Quarter
Medipharm Labs (TSX: LABS) has seen its revenues absolutely implode in a single quarter. The company reported its first quarter
Read more
Medipharm Secures $37.8 Million In Convertible Notes
Medipharm Labs (TSX: LABS) this morning announced that it has secured aggregate gross proceeds of $37.8 million via a private
Read more
Medipharm Announces White Label Agreement With Argentia Gold
Medipharm Labs (TSX: LABS) and Argentia Gold Corp this morning jointly announced a supply agreement, whereby Medipharm will supply Argentia
Read more
Medipharm Labs Delays Q1 Financials, Announces Inventory Impairments
Medipharm Labs (TSX: LABS) this morning announced that it will be delaying its first quarter financial results, with the company
Read more
Champignon Brands Appoints Medipharm Labs CEO Pat McCutcheon to Board
This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its board of directors effective immediately.
Read more
Medipharm Labs Announces White Label Agreement, Provides No Details
Medipharm Labs (TSX: LABS) has entered into its second white label supply agreement with its Australian counterpart for the New
Read more
Rough Week In Cannabis Sector Capped With Gut Punch From Ontario
This first week of April has been the never-ending week for the cannabis industry that has been continuously gut punched
Read more
MediPharm Labs Report sees Quarterly Revenue Drop 25%
This morning MediPharm Labs (TSX: LABS) released their fourth quarter results for the year ended December 31, 2019. The quarter
Read more